Live Breaking News & Updates on தேர்ந்தெடுக்கப்பட்ட உள் கதிர்வீச்சு சிகிச்சை

Stay updated with breaking news from தேர்ந்தெடுக்கப்பட்ட உள் கதிர்வீச்சு சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Terumo is building a Global Therapeutic Interventional Oncology team to offer more therapeutic solution to cancer patients


Terumo is building a Global Therapeutic Interventional Oncology team to offer more therapeutic solution to cancer patients
News provided by
Share this article
Share this article
LEUVEN, Belgium, April 12, 2021 /PRNewswire/ Terumo is proud to announce the launch of its Global Therapeutic Interventional Oncology team as of April 1st, 2021. This reflects Terumo s aspiration to be a Global leader in the field of Interventional Oncology by focusing on improving patient s quality of life and survival.
This organization will be comprised of Medical Strategy, Research & Development, Software Development, Medical Imaging Discovery, and Operations. It will be entirely dedicated to the development of Therapeutic Interventional Oncology solutions for patients with cancer. This team will be led by Laurent Domas, Vice President, Global Interventional Oncology Strategy and Therapy Development. ....

France General , United States , Republic Of , Saudi Arabia , Region Flamande , Laurent Domas , Prnewswire Terumo , Software Development , Healthcare Professionals , Therapeutic Imaging Department , Gustave Roussy Institute , Therapy Development , Research Development , Global Therapeutic Interventional Oncology , Interventional Oncology , Medical Strategy , Medical Imaging Discovery , Therapeutic Interventional Oncology , Vice President , Global Interventional Oncology Strategy , Interventional Systems , Selective Internal Radiation Therapy , Thermal Microwave , Health Care , Therapeutic Imaging , Terumo Interventional Systems ,

NICE backs selective internal radiation therapy for advanced liver cancer


NICE backs selective internal radiation therapy for advanced liver cancer
2nd March 2021
The UK’s National Institute for Health and Care Excellence (NICE) has recommended selective internal radiation therapy (SIRT) for the treatment of advanced liver cancer in final draft guidance.
NICE’s draft guidance recommends the use of SIR-Spheres – made by SIRTEX – and TheraSphere – made by Boston Scientific – for treating advanced liver cancer that can’t be removed surgically and when transarterial therapy is not appropriate.
The recommendation also specifies that these two therapies should only be considered for people with Child-Pugh grade A liver impairment.
Despite limited clinical trial data for SIRTs compared with other treatment options, NICE’s appraisal committee concluded that SIRT may have fewer and more manageable side effects compared to systemic therapy sorafenib. ....

United States , United Kingdom , Meindert Boysen , United Kingdom National Institute For Health , Boston Scientific , Centre For Health Technology Assessment , National Institute , Care Excellence , Health Technology Assessment , Advanced Liver Cancer , Selective Internal Radiation Therapy , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது கிஂக்டம் தேசிய நிறுவனம் க்கு ஆரோக்கியம் , போஸ்டன் அறிவியல் , மையம் க்கு ஆரோக்கியம் தொழில்நுட்பம் மதிப்பீடு , தேசிய நிறுவனம் , பராமரிப்பு சிறப்பானது , ஆரோக்கியம் தொழில்நுட்பம் மதிப்பீடு , தேர்ந்தெடுக்கப்பட்ட உள் கதிர்வீச்சு சிகிச்சை ,